Variable | All (N = 115) | G2 sarcoma (N = 53) | G3 sarcoma (N = 62) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariable analysis | Univariate analysis | Multivariable analysis | Univariate analysis | Multivariable analysis | |||||||
HR (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
Age (in years) | ||||||||||||
< 61 | Ref | Ref | Ref | |||||||||
≥ 61 | 1.951 (.991–3.842) | .053 | 2.482 (.807–7.636) | .113 | 1.446 (.617–3.387) | .396 | ||||||
Sex | ||||||||||||
Male | Ref | Ref | .303 | Ref | ||||||||
Female | .853 (.442–1.646) | .636 | .563 (.189–1.680) | 1.271 (.554–2.915) | .572 | |||||||
KPS | ||||||||||||
< 90 | Ref | Ref | Ref | Ref | Ref | |||||||
≥ 90 | .386 (.197-.756) | .006* | .485 (.238-.988) | .046* | .444 (.144–1.365) | .156 | .372 (.162-.858) | .020* | .577 (.232–1.432) | .236 | ||
Location | ||||||||||||
Other | Ref | Ref | Ref | Ref | ||||||||
Extremity | .532 (.271–1.042) | .066 | .244 (.078-.761) | .015* | .240 (.066-.867) | .029* | .774 (.305–1.963) | .590 | ||||
Tumor size (in cm) | ||||||||||||
< 8.8 | Ref | Ref | Ref | |||||||||
≥ 8.8 | 1.356 (.707–2.603) | .359 | 1.369 (.459–4.079) | .573 | 1.246 (.545–2.852) | .602 | ||||||
Resection margin | ||||||||||||
R0 | Ref | Ref | Ref | Ref | Ref | |||||||
R1/2 | 3.090 (1.336–7.146) | .008* | 2.114 (.884–5.058) | .092 | 4.648 (1.429–15.113) | .011* | 2.252 (.620–8.186) | .218 | 2.137 (.480–9.512) | .319 | ||
n/a | .577 (.137–2.424) | .453 | .477 (.113–2.010) | .313 | - | - | 1.561 (.362–6.731) | .550 | ||||
Therapy | ||||||||||||
Other therapy | Ref | Ref | Ref | Ref | Ref | |||||||
Neoadjuvant RCT | .405 (.165-.994) | .049* | .544 (.212–1.394) | .205 | .830 (.182–3.793) | .810 | .234 (.075-.729) | .012* | .318 (.093–1.090) | .068 | ||
Hyperthermia | ||||||||||||
No | Ref | Ref | Ref | |||||||||
Yes | 1.130 (.433–2.946) | .803 | 1.353 (.295–6.194) | .697 | 1.029 (.296–3.573) | .965 |